Seminar: "Recent Decisions on Market Access and Competition Issues Arising from Patent-Derived Exclusivities in the Pharmaceutical Sector"

Our Founding Attorney, Nuri Melih İnce, delivered a presentation titled ‘Recent Decisions on Market Access and Competition Issues Arising from Patent-Derived Exclusivities in the Pharmaceutical Sector’ at the Intellectual Property Law Symposium hosted by Başkent University on 21 April 2026.

The presentation addressed a range of key issues, including:

• recent judicial decisions and regulatory developments on whether activities related to marketing authorisation, pricing, and reimbursement processes fall within the scope of the Bolar exemption,

  
  

• case law on the compensation of market losses where interim injunctions granted in patent disputes are subsequently lifted,

  
  

• skinny labelling practices and their impact on the market entry of generic products,

  
  

• the European Commission’s approach in treating the obstruction of generic entry through strategic patent filings and withdrawal practices as an abuse of a dominant position,

  
  

• excessive pricing decisions of competition authorities concerning originator medicinal products in the post-COVID-19 period.